ICD-10 code D22.4: Melanocytic nevi of scalp and neck

Key Takeaways

ICD-10 code D22.4 is the billable diagnosis code for melanocytic nevi of the scalp and neck, classified under Chapter 2 Neoplasms (C00-D49).

Documentation must specify anatomical site (Scalp vs. neck) and support clinical necessity to avoid cosmetic-procedure denials.

Atypical or dysplastic nevi with uncertain behavior belong under D48.5, not D22.4 – misassignment is the most common coding error in this category.

Pabau’s dermatology EMR supports ICD-10 code D22.4 workflows with structured digital forms, automated claims, and before-and-after photo documentation.

ICD-10 code D22.4 is the billable ICD-10-CM diagnosis code for melanocytic nevi of the scalp and neck. It establishes the medical necessity behind an excision or evaluation once a benign nevus is confirmed at either the scalp or the neck.

Choosing this site-specific subcode over the unspecified D22.9 is what keeps scalp and neck nevus claims clean. Precise, site-specific coding — the same discipline behind full-body mole mapping in dermatology — justifies each lesion removed.

ICD-10 code D22.4: Definition and clinical description

D22.4 is a billable ICD-10-CM diagnosis code representing melanocytic nevi of the scalp and neck. It sits within Chapter 2 (Neoplasms, C00-D49), under the block D10-D36 (Benign neoplasms, except benign neuroendocrine tumors). The code is valid for fiscal year 2026 reimbursement, as confirmed by the CMS ICD-10-CM code set.

Clinically, melanocytic nevi are benign proliferations of melanocytes. They present as pigmented macules or papules and are classified by anatomical site in the ICD-10-CM tabular list. D22.4 covers nevi on both the scalp and the neck; no separate subcode distinguishes between those two locations. Synonyms used in clinical documentation include “benign neoplasm of skin of neck” and “melanocytic nevus of scalp.”

Accepted nevus types coded under D22.4 when located on the scalp or neck include junctional, compound, and intradermal nevi. Dermoscopic evaluation helps confirm the benign nature of the lesion before applying this code. D22.4 falls directly beneath the parent D22 category, which covers melanocytic nevi across all anatomical sites.

D22 subcategory and code hierarchy overview

Understanding where D22.4 fits within the D22 family helps coders select the most accurate site-specific code and avoid unspecified-code denials. The full D22 subcategory maps anatomical sites to individual billable codes.

Use D22.9 only when documentation genuinely lacks an anatomical site. Payers flag unspecified codes, and the CDC/NCHS ICD-10-CM lookup tool confirms that site-specific codes like D22.4 are preferred wherever the record supports them.

Within the same D10-D36 benign-neoplasm block, coders regularly cross-reference related site-specific entries such as D27.0, D28.0, and D36.0, where the same hierarchy logic drives claim outcomes.

ICD-10 code D22.4 documentation requirements

Insufficient documentation is the leading cause of medical necessity denials when billing for benign nevus excision. The medical record must substantiate both the diagnosis and the clinical reason for removal.

Required documentation elements for D22.4 include:

• Anatomical site: Specify “scalp” or “neck” (Not just “head/neck region”)
• Clinical description: Lesion size, borders, color, and surface characteristics
• Dermoscopy findings: If performed, document pattern analysis and benign conclusion
• Reason for removal: Cosmetic vs. clinical concern (Irritation, rapid growth, atypical features)
• Pathology request: Document specimen submission for CPT 88305 if excision is performed
• Photographs: Pre-procedure images support medical necessity appeals when payers dispute cosmetic classification

Dermatology and aesthetic practices using skin clinic software with structured note templates reduce documentation errors significantly. Pabau’s claims management software flags missing fields before a claim is submitted, giving coders time to correct the record rather than manage a denial.

Standardized digital intake forms capture lesion characteristics at the point of consultation, which feeds directly into the clinical note.

Coding guidelines: D22.4 vs D48.5 and atypical nevi

The most actively debated coding question around melanocytic nevi is whether to use D22.x or D48.5 (Neoplasm of uncertain behavior of skin). The AAPC Codify ICD-10-CM reference confirms that the ICD-10-CM alphabetical index directs “dysplastic nevus” to the neoplasm table, skin, benign, which maps to D22.x by location.

Coding rules for atypical nevi depend on pathology grade:

• Mild dysplasia: Assign D22.4 (Benign, site-specific)
• Moderate dysplasia: Coding controversy exists; many coders apply D22.4 unless the pathologist explicitly labels behavior as uncertain
• Severe dysplasia / uncertain behavior: D48.5 is appropriate when the pathology report supports the classification
• Compound nevi: Coded D22.x by site (Verified by AAPC Codify notation)

Never apply D48.5 based on clinical appearance alone. The code requires pathological confirmation of uncertain behavior. When pathology returns a benign diagnosis, D22.4 remains the correct code for scalp and neck sites.

The same site-specificity logic guides other dermatology diagnoses, from actinic granuloma (L57.5) to rash and nonspecific skin eruption (R21) and viral skin lesions (B09).

CPT codes commonly billed with ICD-10 code D22.4

D22.4 is not a standalone claim. Procedure codes drive reimbursement; the diagnosis code establishes medical necessity. The CPT codes most commonly paired with D22.4 for scalp and neck sites are listed below.

CPT code selection (11420-11426) depends on the excised diameter including margins, not just the visible lesion size. Document the total excised diameter in centimeters in the operative note. CPT 88305 is billable when the specimen is submitted for pathological evaluation.

Payer policies on 88305 denial risk vary, so confirm that the documentation explicitly notes specimen submission. Dermatology teams using dermatology EMR software can attach operative note templates that prompt for excised diameter and specimen handling, reducing the most common CPT coding errors on D22.4 claims.

Document every nevus excision without chasing notes

Pabau gives dermatology and aesthetic practices structured clinical notes, automated claims submission, and before-and-after photo storage. D22.4 workflows become repeatable and denial-resistant.

Book a demo

ICD-9-CM crosswalk and payer billing context

Legacy systems and older audit trails may reference the ICD-9-CM predecessor to D22.4. The direct crosswalk is ICD-9-CM code 216.4 (Benign neoplasm of skin of scalp and neck). This crosswalk is approximate: ICD-9-CM 216.4 mapped all benign skin neoplasms by site without distinguishing melanocytic from non-melanocytic origin.

Any payer correspondence referencing 216.4 in relation to a post-2015 claim should be reviewed for coding-year accuracy.

For US practices, ICD-10-CM is the operative standard under HIPAA-mandated code sets. The D22.4 classification aligns with the WHO ICD-10 international standard but carries US-specific tabular notes and guidelines managed by CMS and NCHS.

International contexts (UK, Canada, Australia) use different coding structures; this article applies to the US ICD-10-CM system. Robust patient record management tracks which code version applies to each historical claim, which is essential during payer audits.

Practices should confirm their EHR supports D22.4 and validates against current fiscal year code tables. Pabau’s AI-assisted clinical documentation helps clinicians structure notes to the level of specificity these claims require.

Insurance considerations for D22.4 claims:

• Medical necessity: Many payers classify benign nevus excision as cosmetic unless documentation supports clinical concern
• Pre-authorization: Some plans require prior approval for excision of benign lesions; verify per payer contract
• Cosmetic exclusion appeals: Include clinical photographs and dermoscopy reports to support necessity
• D22.4 as secondary diagnosis: When malignancy is ruled out post-excision and pathology returns benign, D22.4 may be applied as the confirmed final diagnosis

Practices managing high-volume nevus removal benefit from before-and-after photo documentation as part of a standard pre-excision workflow. Photographs stored against the patient record create an audit trail that supports both clinical decision-making and insurance appeals.

The same site-specificity logic applies uniformly across dermatology coding, whether the diagnosis is psoriasis (L40.0), a common wart (B07.9), or impetiginized dermatoses (L01.1).

Conclusion

Melanocytic nevi of the scalp and neck represent one of the most frequently excised benign skin lesions in dermatology and aesthetic practice. Getting the diagnosis code right is the foundation of a clean claim, and D22.4 is the correct billable code when documentation confirms a benign melanocytic nevus on the scalp or neck.

The most common coding mistake is defaulting to D22.9 (Unspecified site) when the clinical note clearly states the anatomical location.

Pabau’s dermatology and skin practice platform supports structured nevus documentation, automated claim submission, and photo-based audit trails, reducing denial rates for D22.4 claims. To see how the workflow runs end-to-end, book a demo.

Continue your research

List Item #1

List Item #2

Frequently Asked Questions